Gara Jalqabaatti › Kansera Urothelial (Cell Transitional) › Georgia › Atlanta
Qorannoo klinikaalii Kansera Urothelial (Cell Transitional) Atlanta, GA keessatti
Qorannoo 8 Kansera Urothelial (Cell Transitional) f Atlanta fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.
Takkalaa qorannoo (Ingiliffa)
Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →
A Study Comparing the Combination of Pembrolizumab and Sacituzumab Govitecan-hziy Versus Standard of Care in the Treatment of Advanced Urothelial Cancer
Namoota walitti qabaa jiraSadarkaa 3
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
A Phase 1 Study of PLN-101095 in Adults With Advanced or Metastatic Solid Tumors
Namoota walitti qabaa jiraSadarkaa 1
- Winship Cancer Institute of Emory University, Atlanta
Testing the Effectiveness of Two Immunotherapy Drugs (Nivolumab and Ipilimumab) With One Anti-cancer Targeted Drug (Cabozantinib) for Rare Genitourinary Tumors
Namoota walitti qabaa jiraSadarkaa 2
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
Pembrolizumab Plus CA-4948 for the Treatment of Patients With Progressive Metastatic Urothelial Cancer Despite Prior Immunotherapy
Namoota walitti qabaa jiraSadarkaa 1
- Emory University Hospital Midtown, Atlanta
- Emory University Hospital/Winship Cancer Institute, Atlanta
- Emory Saint Joseph's Hospital, Atlanta
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
Namoota walitti qabaa jiraSadarkaa 1
- Emory University - Winship Cancer Institute, Atlanta
Study of INBRX-106 and INBRX-106 in Combination With Pembrolizumab (Keytruda®) in Subjects With Locally Advanced or Metastatic Solid Tumors (Hexavalent OX40 Agonist)
Namoota walitti qabaa jiraSadarkaa 1/2
- Winship Cancer Institute - Emory University, Atlanta
Cabozantinib in Combination With Enfortumab Vedotin for Locally Advanced or Metastatic Urothelial Cancer
Namoota walitti qabaa jiraSadarkaa 1
- Emory University Hospital/Winship Cancer Institute, Atlanta
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
Namoota walitti qabaa jiraQorannoo ilaalaa
- Massive Bio SYNERGY-AI site, Atlanta
Qorannoo Kansera Urothelial (Cell Transitional) magaalota biroo keessatti
- Nashville, TNQorannoo 23
- New York City, NYQorannoo 22
- Houston, TXQorannoo 19
- Dallas, TXQorannoo 18
- Edison, NJQorannoo 18
- Los Angeles, CAQorannoo 17
- Queens, NYQorannoo 15
- Chicago, ILQorannoo 14
- Arlington, VAQorannoo 12
- Boston, MAQorannoo 11
- San Antonio, TXQorannoo 11
- Austin, TXQorannoo 10
Qorannoo biroo Atlanta keessatti
- Saree (Gosoota Hunda)Qorannoo 49
- Kansara Qara'a Non-Small CellQorannoo 47
- Myeloma Baay’eeQorannoo 42
- Saree OljooQorannoo 41
- Kansarii ProstateQorannoo 33
- Leukemia Myeloidii HamaaQorannoo 31
- Kansarii OvariiQorannoo 29
- Kansarii ColorectalQorannoo 29
- Dhibee QaraQorannoo 29
- Kansara MetastatikiiQorannoo 28
- Dhibee Gaddii GuddaaQorannoo 25
- Cufama OnneeQorannoo 25
Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.